Table 2.
Characteristics of subjects.
| Patients Characteristics | Uninfected (n=15) | Infected (n=35) | P | Normal Range | Characteristics type |
|---|---|---|---|---|---|
| Gender | – | basic | |||
| Male | 12 (80%) | 30 (86.0%) | |||
| Female | 3 (20%) | 5 (14.0%) | |||
| Age (years) | 64 (47-80) | 67 (57-82) | 0.240 | ||
| IFN-a, pg/ml | 1.43 (0.31-2.5) | 1.83 (0.78-3.18) | 0.031 | 0-8.5 | Cytokines detection |
| IL-1β, pg/ml | 1.77 (0-23.25) | 8.97 (0-73.67) | 0.023 | 0-12.4 | |
| IL-6, pg/ml | 4.00 (0.1-9.1) | 8.30 (0.25-30.95) | 0.018* | 0-5.4 | |
| IFN-γ, pg/ml | 6.10 (2.18-11.91) | 6.50 (0.44-21.08) | 0.920 | 0-23.1 | |
| IL-10, pg/ml | 0.83 (0.56-1.27) | 0.91 (0.3-4.23) | 0.700 | 0-12.9 | |
| IL-12P70, pg/ml | 0.21 (0-2.1) | 0.06 (0-0.62) | 0.550 | 0-3.4 | |
| IL-17, pg/ml | 1.57 (0.77-5.53) | 2.08 (0.92-14.62) | 0.120 | 0-21.4 | |
| IL-2, pg/ml | 0.61 (0-0.62) | 0.77 (0-2.99) | 0.480 | 0-7.5 | |
| IL-4, pg/ml | 0.64 (0.45-1.54) | 0.63 (0-1.34) | 0.140 | 0-8.56 | |
| IL-5, pg/ml | 1.98 (0.21-6.91) | 2.14 (0-4.96) | 0.380 | 0-3.1 | |
| IL-8, pg/ml | 8.72 (2.55-35.41) | 9.31 (0-80.96) | 0.320 | 0-20.6 | |
| TNF-a, pg/ml | 1.25 (0.04-4.35) | 1.48 (0-7.36) | 0.910 | 0-16.5 | |
| Nitrite (NIT) | 0 (0) | 0.21 (0-1) | 0.100 | Negative (-) | Urinalysis |
| Leukocyte esterase (LE) | 0.86 (0.5-2) | 2.54 (1-4) | 0.000 | Negative (-) | |
| Bacteria count (U BACT), number/μl | 179.82(0-881.8) | 2613.64 (26.6-22218.4) | 0.000 | 0-32.8 | |
| Red blood cell count (RBC), number/μl | 631.79(4.3-4729.7) | 898.67 (0.1-9840.5) | 0.750 | 0.2-13.8 | |
| White blood cell count (WBC), number/μl | 191.99(14.3-385.5) | 2823.35 (7.5-36212.4) | 0.000 | 0-7.1 |
Data are presented as n (%) or means (range).
Bold and underlined number means P<0.05, Wilcoxon test.